Michele Ferreira Ferreira Marques

Dr. Michele Ferreira Ferreira Marques

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LOLaís Albuquerque de Oliveira
Laís Albuquerque de Oliveira
MBMarcelo dos Santos Barbosa
Marcelo dos Santos Barbosa
ATAlex José Leite Torres
Alex José Leite Torres
MCMariana Garcia Croda
Mariana Garcia Croda
BSBruna Oliveira da Silva
Bruna Oliveira da Silva
SSSimone Simionatto
Simone Simionatto
This study assessed the seroprevalence of SARS-CoV-2 in 496 asymptomatic individuals from Mato Grosso do Sul, located in Dourados, the largest periurban indigenous area in Brazil, from January 25 to February 4, 2021. The volunteers participated before receiving their first dose of the CoronaVac inactivated vaccine. For screening, blood samples were collected and analyzed using SARS-CoV-2 rapid tests and the enzyme-linked immunosorbent assay (ELISA). We observed varying trends in total anti-SARS-CoV-2 antibodies across different variables. Seropositivity among the participants tested was 63.70% (316/496) using the rapid test and 52.82% (262/496) were positive using the ELISA method. The majority of participants identified with the Guarani-Kaiowá ethnic group, with 66.15% (217/328), and other ethnic groups with 58.84% (193/328). The median age of the subjects was 30.5 years, with 79.57% (261/328) being femaleThis research showed the elevated seroprevalence of SARS-CoV-2 antibodies in asymptomatic Brazilians. The findings indicate a high seropositivity rate among the asymptomatic indigenous population of Midwest Brazil. This underscores the overlooked status of these communities and underscores the need for targeted national initiatives that emphasize the protection of vulnerable ethnic groups in the fight against COVID-19.

1 January 2022 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
JQJúlio Henrique Ferreira de Sá Queiroz
Júlio Henrique Ferreira de Sá Queiroz
MCMaisa Estopa Correa
Maisa Estopa Correa
TFTiago da Silva Ferreira
Tiago da Silva Ferreira
MMMichele Ferreira Ferreira Marques
Michele Ferreira Ferreira Marques
MBMarcelo dos Santos Barbosa
Marcelo dos Santos Barbosa
SSSimone Simionatto
Simone Simionatto
Syphilis is caused by the bacterium Treponema pallidum. The diagnosis is based on clinical data and serological analysis; however, the sensitivity and specificity of such tests may vary depending on the type of test and stage of the infection. In order to overcome this premise, this study utilized the polymerase chain reaction (PCR) for the detection of T. pallidum DNA in whole blood samples of patients with syphilis. The blood samples from patients with or without symptoms of syphilis, but with positive results in enzyme-linked immunosorbent assay (ELISA), were included in this study. A venereal disease research laboratory (VDRL) test was performed for all collected sera samples. For PCR, the T. pallidum DNA was extracted from the collected blood samples and a specific primer set was designed to amplify 131 nucleotides of polA (Tp0105). The specificity of the primers was evaluated with the DNA of 17 different pathogens. From a total of 314 blood samples reactive in ELISA, 58.2% (183/314) of the samples were reactive in the VDRL test. In the PCR, 54% (168/314) of the ELISA-reactive samples were positive. In both tests (VDRL and PCR) 104 samples were positive. Of 104 positive samples for both tests, 71 were at the latent stage. Based on these results, it can be concluded that PCR with the designed set of primers can be utilized as a diagnostic method for T. pallidum detection in blood samples of patients with syphilis, especially those with latent infection. In addition, it can be utilized as a supplement for serological methods to improve the diagnosis of syphilis.

10 April 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
LOLaís Albuquerque de Oliveira
Laís Albuquerque de Oliveira
IMIsa Rita Brito de Morais
Isa Rita Brito de Morais
MBMarcelo dos Santos Barbosa
Marcelo dos Santos Barbosa
SMSilvana Beutinger Marchioro
Silvana Beutinger Marchioro
LMLayla Oliveira Campos Leite Machado
Layla Oliveira Campos Leite Machado
SSSimone Simionatto
Simone Simionatto
Introduction: Although the adaptive immune responses to the CoronaVac vaccine are known, their dynamics in indigenous communities remain unclear. In this study, we assessed the humoral and cellular immune responses to CoronaVac (Sinovac Biotech Life Sciences, 2021 NCT05225285, Beijing, China), in immunized Brazilian indigenous individuals. Methods: We conducted a prospective cohort study on indigenous Brazilian people between February 2021 and June 2021. Analyses of immune responses were carried out before (T1) and after a vaccination schedule was completed (T2). Demographic data were collected using a questionnaire. Results: We initially included 328 patients; among them, 120 (36.6%) had no SARS-CoV-2 antibodies. Peripheral blood mononuclear cells (PBMCs) were collected from 106 patients during follow-up visits, of which 91 samples were analyzed by immunophenotyping assay to detect SARS-CoV-2-specific memory T-cell response. Post-vaccination, the levels of memory B-cells and Natural Killer T-lymphocytes increased. Bororó village residents, females, and Terena ethnic group members had higher levels of anti-spike IgG antibodies post-vaccination, whereas alcohol and tobacco users had lower concentrations. Conclusions: To our best knowledge, this was the first comprehensive assessment of antibody and T-cell responses against CoronaVac vaccination in indigenous patients. Our findings showed that antibody response and T-cell immunity against SARS-CoV-2 were present in most patients following the vaccination schedule.

23 March 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
GBGabriel Teixeira Brito
Gabriel Teixeira Brito
MMMichele Ferreira Ferreira Marques
Michele Ferreira Ferreira Marques
ASAlex Souza da Silva
Alex Souza da Silva
RLRicardo de Lucia
Ricardo de Lucia
JCJulio Croda
Julio Croda
SSSimone Simionatto
Simone Simionatto
We estimated the prevalence of screening for prostate cancer in indigenous people in Brazil. We also studied how ethnicity, age, social conditions, lifestyle, and history of sexually transmitted infections are associated with altered prostate-specific antigen (PSA) values. This is a cross-sectional study with indigenous people, ≥ 40 years old, from Dourados reserve, Mato Grosso do Sul, Brazil. The patients underwent total PSA and rapid tests for syphilis, HIV, and hepatitis B and C. PSA values were compared with sociodemographic conditions, presence of urological symptoms, clinical data on sexually transmitted infections, lifestyle, and family history of cancer. Out of the 498 men invited to participate in the study, 31.53% (157/498) were ≥ 40 years old and were included. The mean (±SD) age was 54.75 (±11.23) years, and 78.3% (123/157; 95% CI: 0.71–0.84) of the population never underwent any preventive examination for prostate cancer. The mean PSA value was 0.081 ng/mL for the 157 participants, and 4.4% (7/157) had > 2.5 ng/mL and 1.9% (3/157) had values ≥ 4 ng/mL. Rapid tests for STIs showed that 5.73% (9/157) of the participants had syphilis and 0.64% (1/157) had HIV, and Hepatitis B and C virus infection. The results showed that most indigenous people ≥ 40 years never underwent any preventive examination for prostate cancer, and 4.4% had an altered PSA exam result. Future studies should assess the factors that hinder adherence to prostate cancer screening, as well as the existence of a pathophysiological correlation between the occurrence of prostate cancer and STIs.